The question of access
This article summarizes recent health-related developments, focusing on the accessibility and affordability of essential medicines and vaccines. It also covers regulatory updates regarding food safety, specifically nutrition labeling and the standardization of dairy products like paneer.
Why it matters
It highlights critical public health issues in India, including drug pricing, regulatory oversight of pharmaceuticals, and the importance of immunization across different age groups.
(In the weekly Health Matters newsletter, Athira Elssa Johnson writes about getting to good health, and staying there. You can subscribe here to get the newsletter in your inbox.)
A treatment can make a difference only when patients can access it. The cost of medicines, their safety and regulation, and whether people can get the care they need are all part of that question. This week, our coverage also looks at vaccination, infectious diseases, artificial intelligence, prevention and new medical research.
Questions around the cost of medicines came into focus after the Supreme Court described the overpricing of essential cancer drugs as “ broad daylight dacoity”. The report examines concerns around medicine prices and what they mean for access to treatment.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in